RE:RE:RE:RE:RE:POC in humans has been acheived is that it I do think SPCEO is right. I can't see any significant efficacy update, I can't actually see how any dial moving new data could have arisen. In fact I'd just put these posters into the box-ticking category. They are just doing what any responsible clinical program would/should do in making their long term data publically available.
The only real hope for the cancer program seems to lie with the last 6 part 3 patients, I could easily be wrong.
Saurus100 wrote: Rusty, With all due respect, the press release's title and content say, "It will present long-term efficacy, safety, and pharmacokinetic (PK) data." Therefore, I expect new information regarding long-term efficacy, aren't you? I agree with all of you; we have been disappointed many times... But when you say the data they will present is not focused on efficacy, is that a feeling you have, or is it based on a conversation you had with management?